The importance of the pharmaceutical professional in the quality of life of elderly diabetic patients
DOI:
https://doi.org/10.33448/rsd-v9i7.3777Keywords:
Diabetes Mellitus; Seniors; Pharmaceutical attention.Abstract
Diabetes Mellitus (DM) is characterized by an increase in the concentration of glucose in the bloodstream due to insulin deficiency. There are two types of Diabetes Mellitus, in type 1 DM, when the individual's pancreas produces little or no insulin, requiring daily insulin injections. Only 10% of diabetics have DM1, manifesting mainly in children and adolescents. Type 2 DM also appears in children and young people, but is more common after the age of 40, in overweight and elderly people, in this situation the pancreas continues to produce insulin, but the body becomes resistant to its effects. For therapeutic intervention in diabetic patients, it is important to highlight that non-drug and drug treatment should be used. Drug treatment can be done through the use of insulin and / or oral antidiabetics (ADOs) to establish glycemic control and promote a decrease in glycated hemoglobin levels. Given the importance of the theme, the present study aimed to investigate the incidence of elderly patients with Diabetes Mellitus in an elderly shelter, as well as the type of drug treatment used. For this procedure, an exploratory, descriptive and retrospective study was carried out, with a qualitative and quantitative approach, by collecting data from the information bank of an elderly shelter in Teresina-PI, in September 2019. More men were found, with the predominant age group of 70 years and a 13% incidence of diabetics, with equal numbers of men and women. In this universe of diabetics, glibenclamide (oral antidiabetic) predominantly led the use, without the existence of any insulin dependent patient. Thus, we can conclude that the important research showed a low incidence of diabetics in this researched shelter, however the relationship between Diabetes and the elderly is a reality that requires the intercession of a prepared multiprofessional team. It is worth highlighting the importance of the pharmaceutical professional working directly with Family Health Care, thus providing a better treatment and consequently better quality of life for the elderly patient.
References
Associação Americana de Diabetes. Abordagens farmacológicas para o tratamento glicêmico: Standards of Medical Care in Diabetes. Cuidados com o diabetes,41(Supl 1), S73, 2018.
Barros, B. P. D. (2014). Práticas do autocuidado por idosos diabéticos em instituições de longa permanência (Master's thesis, Universidade Federal de Pernambuco).
Campos & Reis, L. P. H. Adequação da metodologia dáder em pacientes hospitalizados com pé diabético: abordagem em atenção farmacêutica. 2014. 281 f. Dissertação (Pós-Graduação em Ciências Farmacêuticas) – Universidade Federal do Ceará, Fortaleza, 2005. Disponível em: Acesso em: 09 set. 2018
Costa, J. D. A., Balga, R. S. M., Alfenas, R. D. C. G., & Cotta, R. M. M. (2011). Promoção da saúde e diabetes: discutindo a adesão e a motivação de indivíduos diabéticos participantes de programas de saúde. Ciência & Saúde Coletiva,16(3), 2001-2009.
Davies, M. J., Gross, J. L., Ono, Y., Sasaki, T., Bantwal, G., Gall, M. A., & BEGIN B. (2014). Efficacy and safety of insulin degludec given as part of basal–bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26‐week randomized, open‐label, treat‐to‐target non‐inferiority trial. Diabetes, Obesity and Metabolism, 16(10), 922-930.
Francisco, P. M. S. B., Belon, A. P., Barros, M. B. D. A., Carandina, L., Alves, M. C. G. P., Goldbaum, M., & Cesar, C. L. G. (2010). Diabetes auto-referido em idosos: prevalência, fatores associados e práticas de controle. Cadernos de saúde pública, 26(1), 175-184.
Géssica, C. L.; Murilo, J. F. Cristhyano, P. M. & Nicolli, B. S. Atenção farmacêutica a pacientes diabéticos tipo 2. Revista Científica Online. V.11, n1, 2019.
Giacobo, S. T., Gonçalves, C. B. C., & Hahn, S. R. (2015). Planejamento estratégico situacional aplicado à atenção farmacêutica: experiências e possibilidades. Revista Eletrônica de Farmácia, 12(4).
Gonçalves, G. C., de Barros, J. M., de Farias Morais, H. G., da Silva Domingos, N. R., Almeida, D. R. D. M. F., Pinheiro, J. C.& Barboza, C. A. G. (2019). Saúde e políticas públicas para idosas de um abrigo: relato de experiência/Health and public policies for elderly in a shelter: experience report. Brazilian Journal of Health Review, 2(6), 5968-5973.
Lehninger, A. L. Princípios de bioquímica. 5ª.ed. São Paulo: Sarvier,2015. LEITE, Silvana Nair. Pontos Básicos de um Programa de Educação ao Paciente com Diabete Melito Tipo 1. Arq. Bras. Endócrino Metab. V. 52, n.2, p. 233-242. 2010.
Maganha, C. A., Vanni, D. G. B. S., Bernardini, M. A., & Zugaib, M. (2013). Tratamento do diabetes melito gestacional. Revista da associação médica brasileira,49(3), 330-334.
Melo, S. G. A. (2016). Avaliação da qualidade de vida facetada e global em idosos com diabetes mellitus.
Odegard, P. S., Goo, A., Hummel, J., Williams, K. L., & Gray, S. L. (2005). Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Annals of Pharmacotherapy, 39(3), 433-440.
Oyer, D.S (2013). The science of hypoglycemia in patients with diabetes. Current diabetes reviews, 9(3), 195-208
Pagotto, V., Silva, V. A. P. D., Pereira, L. V., & Santos, D. P. M. A. D. (2016). Comparação da funcionalidade de idosos residentes em duas modalidades institucionais.
Siqueira, A. J., & de Sousa, E. A. (2012). O conhecimento do cliente/paciente de drogarias em relação à atenção farmacêutica.
Sociedade Brasileira de Diabetes. Diretrizes da sociedade Brasileira de Diabetes (2019-2020). São Paulo: A.C Farmacêutica; 2019.
Zanetti, M. L., Biagg, M. V., Santos, M. A. D., Péres, D. S., & Teixeira, C. R. D. S. (2008). O cuidado à pessoa diabética e as repercussões na família. Revista Brasileira de Enfermagem, 61(2), 186-192.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
